Filed: 8/9/2023ACC: 0001012975-23-000327
📋 What this filing means
ARCH VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $161.95M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$161.95M
Total AUM (reported)
54.90M
Total Shares
Allocation by class
COM$161.95M100.0%
Portfolio Concentration
Top 3$135.76M83.8%
4–10$26.19M16.2%
Top 3 weight
83.8%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 54.90M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
54.90M
shares
% of voting shares100.0%
Investment Discretion (by position count)
Sole6
Shared0
Other0
Dominant voting typeNone · 100.0% of voting shares
Institutional Holdings6
Rows:
EQRX, INC.
SOLEShares36.34M
TypeSH
Market value$67.58M
41.73%
Sole
0.00
Shared
0.00
None
36.34M
VERVE THERAPEUTICS, INC.
SOLEShares2.01M
TypeSH
Market value$37.67M
23.26%
Sole
0.00
Shared
0.00
None
2.01M
ERASCA, INC.
SOLEShares11.06M
TypeSH
Market value$30.51M
18.84%
Sole
0.00
Shared
0.00
None
11.06M
DENALI THERAPEUTICS, INC.
SOLEShares693.75K
TypeSH
Market value$20.47M
12.64%
Sole
0.00
Shared
0.00
None
693.75K
SINGULAR GENOMICS SYSTEMS, INC.
SOLEShares3.80M
TypeSH
Market value$3.15M
1.95%
Sole
0.00
Shared
0.00
None
3.80M
UNITY BIOTECHNOLOGY, INC.
SOLEShares1M
TypeSH
Market value$2.56M
1.58%
Sole
0.00
Shared
0.00
None
1M
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
EQRX, INC.SOLE | COM | 36.34M | SH | $67.58M 41.73% | 0.00 | 0.00 | 36.34M |
VERVE THERAPEUTICS, INC.SOLE | COM | 2.01M | SH | $37.67M 23.26% | 0.00 | 0.00 | 2.01M |
ERASCA, INC.SOLE | COM | 11.06M | SH | $30.51M 18.84% | 0.00 | 0.00 | 11.06M |
DENALI THERAPEUTICS, INC.SOLE | COM | 693.75K | SH | $20.47M 12.64% | 0.00 | 0.00 | 693.75K |
SINGULAR GENOMICS SYSTEMS, INC.SOLE | COM | 3.80M | SH | $3.15M 1.95% | 0.00 | 0.00 | 3.80M |
UNITY BIOTECHNOLOGY, INC.SOLE | COM | 1M | SH | $2.56M 1.58% | 0.00 | 0.00 | 1M |